Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
ablation, androgen, aspect, carcinoid, circulating, count, CTC, heard, imaging, magnetic, myeloma, neuroendocrine, pancreatic, preparatory, relapsed, resonance, thirteen
Removed:
acting, adding, annually, apportioned, biologic, brand, branded, calendar, coincide, comparative, concentration, dispensed, distributed, enrolled, exert, extension, family, fee, framework, gap, generic, greatest, holding, importance, licensure, manufacturer, Molecular, nondeductible, outpatient, oversee, Poverty, preceding, requirement, retroactive, reviewing, submitting, Symposium, viewed, widely
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 Side Letter to Sublease Between Exelixis, Inc. and Nodality, Inc.
- 10.2 First Ammendment to Sublease Between Exelixis, Inc. and Nodality, Inc.
- 10.3 Consent of HCP Life Science Reit, Inc. to First Ammendment to Sublease Between Exelixis, Inc. and Nodality, Inc.
- 31.1 Certification of CEO Required by Rule 13A-14(A) or Rule 15D-14(A)
- 31.2 Certification of CFO Required by Rule 13A-14(A) or Rule 15D-14(A)
- 32.1 Certification of CEO and CFO Required by Rule 13A-14(B) or Rule 15D-14(B)
Related press release
EXEL similar filings
Filing view
External links